Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Viral persistence, liver disease and host response in Hepatitis C-like virus rat model

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease

    Publikation: Bidrag til tidsskriftReviewpeer review

  • International Variceal Bleeding Observational Study Group and Baveno Cooperation
Vis graf over relationer

Patients admitted with acute variceal bleeding (AVB) and Child-Pugh C score (CP-C) or Child-Pugh B plus active bleeding at endoscopy (CP-B+AB) are at high risk for treatment failure, rebleeding, and mortality. A preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) has been shown to improve survival in these patients, but its use in clinical practice has been challenged and not routinely incorporated. The present study aimed to further validate the role of preemptive TIPS in a large number of high-risk patients. This multicenter, international, observational study included 671 patients from 34 centers admitted for AVB and high risk of treatment failure. Patients were managed according to current guidelines, and use of drugs and endoscopic therapy (D+E) or p-TIPS was based on individual center policy. p-TIPS in the setting of AVB is associated with a lower mortality in CP-C patients compared with D+E (1 year mortality 22% vs. 47% in D+E group; P = 0.002). Mortality rate in CP-B+AB patients was low, and p-TIPS did not improve it. In CP-C and CP-B+AB patients, p-TIPS reduced treatment failure and rebleeding (1-year cumulative incidence function probability of remaining free of the composite endpoint: 92% vs. 74% in the D+E group; P = 0.017) and development of de novo or worsening of previous ascites without increasing rates of hepatic encephalopathy. Conclusion: p-TIPS must be the treatment of choice in CP-C patients with AVB. Because of the strong benefit in preventing further bleeding and ascites, p-TIPS could be a good treatment strategy for CP-B+AB patients.

OriginalsprogEngelsk
TidsskriftHepatology (Baltimore, Md.)
Vol/bind69
Udgave nummer1
Sider (fra-til)282-293
Antal sider12
ISSN0270-9139
DOI
StatusUdgivet - jan. 2019

ID: 54904154